tradingkey.logo

Telix Pharmaceuticals Provides Regulatory Update On TLX250-CDX

ReutersAug 28, 2025 1:38 AM

- Telix Pharmaceuticals Ltd TLX.AX:

  • PROVIDES REGULATORY UPDATE ON TLX250-CDX

  • RECEIVES FDA COMPLETE RESPONSE LETTER FOR TLX250-CDX

  • FDA REQUESTS ADDITIONAL DATA FOR TLX250-CDX MANUFACTURING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI